ST Segment Detection Study

Stopped early

Conditions studied: Coronary Artery Disease

In brief

The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.

Key facts

Study ID

NCT00930969

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

175

Starts

2008-04-01

Expected to finish

2011-03-01

Last updated by the study team

2019-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is indicated for an ICD implantation
• AND subject must meet ONE of the following:
• Prior acute coronary event
• Previously underwent Percutaneous Coronary Intervention (PCI) or stent procedure
• Multivessel disease
• Positive stress test completed with evidence of ischemic heart disease, as determined by physician, and no subsequent successful revascularization

You may not qualify if…

• Subject is currently dependent on ventricular pacing
• Subject has Left Bundle Brunch Block (LBBB) and/or wide QRS
• Subject has chronic Atrial Fibrillation (AF)
• Subject has dementia
• Subject is indicated for a single chamber device
• Subject requires a right sided or abdominal ICD implant
• Subject is pregnant or in fertile age without secure birth control
• Subject has New York Heart Association (NYHA) class IV or refractory heart failure
• Subject is not expected to survive greater than 12 months
• Subject is participating in other confounding research studies

Where it is running

• Study site — Anchorage, Alaska, United States
• Study site — Brandon, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Davenport, Iowa, United States
• Study site — Boston, Massachusetts, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Kansas City, Missouri, United States
• Study site — Mineola, New York, United States
• Study site — Stony Brook, New York, United States
• Study site — Gastonia, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Nashville, Tennessee, United States
• Study site — Austin, Texas, United States
• Study site — Burlington, Vermont, United States
• Study site — Richmond, Virginia, United States
• Study site — Morgantown, West Virginia, United States
• Study site — Linz, Austria
• Study site — Liège, Belgium
• Study site — Copenhagen, Denmark
• Study site — Berlin, Germany
• Study site — Heidelberg, Germany
• Study site — Nuremberg, Germany
• Study site — Zwolle, Netherlands
• Study site — Kristiansand, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.